WEDNESDAY, Dec. 18, 2024 -- Respiratory Syncytial Virus Prefusion F (RSVpreF) vaccination is effective against RSV-related lower respiratory tract...

WEDNESDAY, Dec. 11, 2024 -- The burden of respiratory syncytial virus (RSV) in young children continues to be high in the United States, according to...

WEDNESDAY, Dec. 11, 2024 -- The burden of respiratory syncytial virus (RSV) in young children continues to be high in the United States, according to...

Northumberland Hills Hospital (NHH) has joined health care providers across Ontario in offering a new serum that can help prevent Respiratory...

Starting in 2025, Tasmania will embark on a pioneering effort to safeguard its youngest residents from respiratory syncytial virus (RSV) with a...

Only 24 babies were hospitalised with RSV since the vaccination programme started, a significant fall from the 413 cases in the same period last year.

Russia has announced the development of a pioneering mRNA vaccine against cancer, promising free access to patients by early 2025.

Russia has announced the development of a pioneering mRNA vaccine against cancer, promising free access to patients by early 2025.

The spokesperson for the Egyptian Health Ministry, Hossam Abdel-Ghaffar has refuted rumors of a cholera outbreak in Egypt. In a phone interview with...

The Russian Ministry of Health’s Radiology Medical Research Center has announced the development of a cancer vaccine, which will reportedly be...